Kenneth Attie
VP, Clinical Dev & Med Affairs, Altus Pharmaceuticals Inc.
Companies
- Enliven Therapeutics, Inc.SVP, CMO Jan 28, 2021 to Feb 1, 20221
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Enliven Therapeutics, Inc. ELVN34,100 shares2$1.3M at $37.32Jan 28, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 28, 2022Granted 34,100 shares of Enliven Therapeutics, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAREnliven Therapeutics, Inc., SVP, CMO
- 2